Skip to content

Study · Animal study (in vivo) · mouse · 1989

2 results

Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice.

Favalli C, Mastino A, Jezzi T, Grelli S, Goldstein AL, Garaci E

International journal of immunopharmacology1 Jan 1989Cited by 40 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In immunosuppressed tumor-bearing mice, thymosin alpha‑1 for 4 days followed by interferon restored normal NK cell activity, where interferon alone gave lower or no improvement.

    In plain wordsIn tumor-bearing mice, thymosin alpha‑1 followed by interferon restored NK cell activity better than interferon alone.

    Outcome
    IncreaseNK cell activity
    Study

    mousen: not reported in source

    tumor-bearing, immunosuppressed mice
    Comparator
    IFN alone
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    200 micrograms/kg · 4 daysAs given in this study (mouse).

    Source sentences

    Summary
    On the other hand, the same treatment led to lower or no improvement of NK responses if the treatment was given 13 or 17 days after tumor inoculation, at a time when tumor growth causes immunosuppression. However, combination treatment with TH (200 micrograms/kg) for 4 days, followed by IFN was foun…
    1 context sentence
    Summary · context
    We have investigated the possibility of thymosin alpha 1 (TH) cooperating with alpha beta-interferon (IFN) in boosting natural killer (NK) activity in tumor-bearing, immunosuppressed mice in vivo.

Studies that did not test the peptide alone1

In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin alpha-1.

  1. 02AnimalNot a test of Thymosin alpha-1 aloneAnimal study (in vivo)Mechanism

    In tumor-bearing mice, killer cells stimulated by thymosin alpha‑1 plus interferon had phenotypic characteristics of NK cells.

    In plain wordsIn tumor-bearing mice, the killer cells raised by thymosin alpha‑1 plus interferon looked like NK cells.

    Outcome
    Not applicablePhenotype of killer cells after combined treatment
    Study

    mousen: not reported in source

    tumor-bearing, immunosuppressed mice
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Selective depletion of antigen-positive cells showed that killer cells stimulated by combination treatment with TH and IFN seem to bear phenotypic characteristics of NK cells.
    1 context sentence
    Summary · context
    We have investigated the possibility of thymosin alpha 1 (TH) cooperating with alpha beta-interferon (IFN) in boosting natural killer (NK) activity in tumor-bearing, immunosuppressed mice in vivo.

    In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.